RE:RE:RE:RE:RE:RE:RE:Cipher Pharma has price target cut at Stifel Canada6 cents to reach the .90 target. WOW what a genius. Sorry for the sarcasm :). I re-read the conf call transcript. Its clear that they are working with Bausch to resolve this. So dont think it will be a long drawn process or expensive one. Other than that they lost some sales momentum. With COVID they have time to resolve it. I think it will be sooner than later. Also, with Abrobica LD, very very imp point is to convert existing prescriptions to LD formulation and that can't be made generic. So LD is protected. I am sure Sun is one of their US partners that have shown interest in marketing tie-up. Sun has presence in Canada as well. And they had a great partnership with CPH for this one product. Sunny Days!